Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: A meta-analysis of randomized controlled trials.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: A meta-analysis of randomized controlled trials.
- Published In:
- British journal of clinical pharmacology, 87(11), 4140-4149 (2021)
- Authors:
- Simental-Mendía, Luis E, Sánchez-García, Adriana, Linden-Torres, Enrique, Simental-Mendía, Mario
- Database ID:
- RPEP-05763
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05763APA
Simental-Mendía, Luis E; Sánchez-García, Adriana; Linden-Torres, Enrique; Simental-Mendía, Mario. (2021). Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: A meta-analysis of randomized controlled trials.. British journal of clinical pharmacology, 87(11), 4140-4149. https://doi.org/10.1111/bcp.14855
MLA
Simental-Mendía, Luis E, et al. "Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: A meta-analysis of randomized controlled trials.." British journal of clinical pharmacology, 2021. https://doi.org/10.1111/bcp.14855
RethinkPeptides
RethinkPeptides Research Database. "Impact of glucagon-like peptide-1 receptor agonists on adipo..." RPEP-05763. Retrieved from https://rethinkpeptides.com/research/simental-mendia-2021-impact-of-glucagonlike-peptide1
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.